Erasca Inc (ERAS) Stock Price Today | The Dividend Tracker

Erasca Inc (ERAS)

$2.56 -$0.04 (-1.71%) 4:38 PM 12/13/24

NASDAQ | $USD | Biotechnology

Stock Data

Market Cap

$856.66M
Day's Range

$2.56 - $2.66
Volume

1,294,343
52 Week Low / High

$1.64 - $3.45
PE Ratio

-
PEG Ratio

-
Dividend Frequency

-

ERAS's Dividend

-: Amount
-: Dividend Yield
-: Payment Date
-: Annual Dividend Amount
: Dividend Streak

Hypothetical 10k Investment Jan 1, 2020

: Capital Growth
: Dividend Return to Date
: Dividend Payout year Est.
: Expenses
: Total Return
: Total Return %

Analyists Ranking

3: Strong Buy
4: Buy
1: Hold
0: Sell
0: Strong Sell
$9.71: Target Price

Company News

Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials — Feb 14th, 2024

Erasca, Inc. Naporafenib is a potential first-in-class and best-in-class pan-RAF inhibitor in multiple RAS/MAPK pathway-driven tumors Initial SEACRAFT-1 Phase 1b combination data in RAS Q61X solid tumors expected between Q2-Q4 2024 Initiation of pivotal SEACRAFT-2 in NRASm melanoma expe...

Similar Stocks

DNTH

Dianthus Therapeutics Inc.
AUTL

Autolus Therapeutics Ltd
CDMO

Avid Bioservices Inc
CRGX

Cargo Therapeutics, Inc. Common Stock

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free